Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study

Summary

The purpose of this study is to establish a multi-center clinical registration platform, to form the real world evidence of New Blood Syndrome Theory intervention in psoriasis, and to evaluate the therapeutic advantages of New Blood Syndrome Theory therapy in the clinical effective and recurrence rate of psoriasis vulgaris.

Conditions

• Psoriasis

Interventions

DRUG

Oral Chinese Herbal Medicine of Clearing heat and Cooling blood therapy

Oral Chinese Herbal Medicine of Clearing heat and Cooling blood therapy, warm water decoction, 1 dose/day, divided into 2 times, 180 \~ 200ml each time for 8 weeks.

DRUG

Oral Chinese Herbal Medicine according with syndrome differentiation therapy

Oral Chinese Herbal Medicine according with syndrome differentiation therapy, warm water decoction, 1 dose/day, divided into 2 times, 180 \~ 200ml each time for 8 weeks.

DRUG

Oral Chinese Herbal Medicine of Promoting blood circulation and Removing blood stasis therapy

Oral Chinese Herbal Medicine of Promoting blood circulation and Removing blood stasis therapy, warm water decoction, 1 dose/day, divided into 2 times, 180 \~ 200ml each time for 8 weeks.

Sponsors & Collaborators

• Zhejiang Provincial Hospital of TCM

  collaborator OTHER

• Shanghai Dermatology Hospital

  collaborator OTHER

• The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

  collaborator OTHER

• Changhai Hospital

  collaborator OTHER

• Shanghai 10th People's Hospital

  collaborator OTHER

• Beijing Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Wuhan No.1 Hospital

  collaborator OTHER

• Jiangsu Province Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Chinese Medicine Hospital Affiliated to Southwest Medical University

  collaborator UNKNOWN

• First Affiliated Hospital of Heilongjiang Chinese Medicine University

  collaborator OTHER

• The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

  collaborator OTHER

• The Second Affiliated Hospital of Jiangxi University of TCM

  collaborator UNKNOWN

• The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

  collaborator OTHER

• The Guangxi Zhuang Autonomous Region Institute of Dermatology and control

  collaborator UNKNOWN

• The First Affiliated Hospital of Guiyang College of TCM

  collaborator UNKNOWN

• The Second People's Hospital Affiliated to Fujian University of TCM

  collaborator UNKNOWN

• Gansu University of Chinese Medicine

  collaborator OTHER

• Shanxi Provincial Hospital of Traditional Chinese Medicine

  collaborator UNKNOWN

• Shijiazhuang Hospital of Traditional Chinese Medicine

  collaborator UNKNOWN

• Shanghai Yueyang Integrated Medicine Hospital

  lead OTHER

Principal Investigators

• Jia Zhou · Department of dermatology, Shanghai Yueyang Integrated Medicine Hospital, Shanghai

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-06-01

Primary Completion

2021-12-31

Completion

2021-12-31

Countries

• China

Study Locations